...
首页> 外文期刊>Open Journal of Obstetrics and Gynecology >Distribution of High-Risk Human Papillomavirus Genotypes in Precancerous Cervical Lesions in Ouagadougou, Burkina Faso
【24h】

Distribution of High-Risk Human Papillomavirus Genotypes in Precancerous Cervical Lesions in Ouagadougou, Burkina Faso

机译:布基纳法索瓦加杜古癌前宫颈病变中高危型人乳头瘤病毒基因型的分布

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Aims: We aimed at identifying the high-risk HPV genotypes associated with high-grade dysplastic cervical lesions in Burkina Faso. The available vaccines to Burkina Faso only protect against two high risk HPV genotypes: HPV 16 and 18. Are the genotypes identified in the high-grade precan-cerous lesions in this survey covered by the available vaccines? Methods: The detection and genotyping of high-risk HPV have been conducted based on 118 formalin-fixed and paraffin-embedded archived tissues using the “HPV Genotypes 14 Real-TM Quant” (Sacace biotechnologies®, Italy) kit allowing for the detection of fourteen high-risk HPV genotypes: HPV 16, 31, 18, 39, 45, 59, 33, 35, 56, 68, 51, 52, 58 and 66. Results: The prevalence of high-risk HPV infections was 48.8% based on the appropriate PCR results (21/43). The most common HPV genotypes were HPV 39 (21.7%), HPV 35 (13.0%) and HPV 45 (13.0%). Two cases of multiple infections between HPV 39 - 45 and HPV 39 - 59 have been observed. HPV 16 was not detected in this study. Conclusions: We noted a high prevalence rate for HPV 39, HPV 35 and HPV 45, which are not covered by the commercial vaccines. We also found that the prevalence of HPV 18 was very low in this study and HPV 16 was not detected.
机译:目的:我们旨在确定与布基纳法索的高度不典型增生性宫颈病变相关的高风险HPV基因型。布基纳法索可用的疫苗只能预防两种高风险的HPV基因型:HPV 16和18。在本次调查中,在高级别癌前病变中鉴定出的基因型是否被可用疫苗覆盖?方法:使用“ HPV Genotypes 14 Real-TM Quant”(意大利Sacace biotechnologies&reg)试剂盒,基于118个福尔马林固定和石蜡包埋的存档组织进行了高风险HPV的检测和基因分型,可检测14种高危HPV基因型:HPV 16、31、18、39、45、59、33、35、56、68、51、52、58和66。结果:根据以下数据,高危HPV感染率为48.8%适当的PCR结果(21/43)。最常见的HPV基因型是HPV 39(21.7%),HPV 35(13.0%)和HPV 45(13.0%)。已观察到2例HPV 39-45和HPV 39-59之间的多重感染。在这项研究中未检测到HPV 16。结论:我们注意到HPV 39,HPV 35和HPV 45的高患病率,这在商业疫苗中并未涵盖。我们还发现,在这项研究中,HPV 18的患病率很低,未检测到HPV 16。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号